Atakent (business cooperation center)

EQS-News: EVOMEDIS Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation

Retrieved on:

Donnerstag, Dezember 7, 2023

Burns, Medical school, Regenerative medicine, Orphan, Atakent (business cooperation center), Partnership, European Medicines Agency, Transfusion medicine, ATMP, RESEARCH, Serology, Wound healing, GMP, Pharmaceutical industry, Nursing, Austria, Germany

Investing in the future of burn medicine: Alliance to develop new cell-based therapy

Key Points:

Investing in the future of burn medicine: Alliance to develop new cell-based therapy
Graz, Austria, 23 November 2023 – EVOMEDIS GmbH (EVOMEDIS), an R&D stage life science company developing next-generation wound healing solutions, today announced the initiation of a strategic partnership with the Medical University of Graz (MedUni) and COREMED (Cooperative Center for Regenerative Medicine / JOANNEUM RESEARCH Forschungsgesellschaft mbH) to propel the shift from wound care to wound healing through innovative solutions.
EVOMEDIS has pledged an investment of €1.5 million over a span of two years for a collaborative project.
We have set up our operations at MedUni, which is part of the Medical Science City Graz (MSCG).
This perfectly aligns with our strategy of working closely with local partners to develop new innovations for wound healing up to clinical proof-of-concept.

GNEC Global New Economy Conference 2023|Global Tycoons and Industrial Leaders Gather in Macao for Crossover Discussion on the Future of Intelligent Health

Retrieved on:

Donnerstag, September 7, 2023

University, Stanford University, Speech, Culture, National Academy of Sciences, Chinese Academy of Sciences, Multimedia, Development, Atakent (business cooperation center), National academy, Guangdong–Hong Kong–Macao Greater Bay Area, Sport, Growth, Pharmacology, Scientific method, Conference, Creative industries, Microsoft, Science

MACAO, Sept. 7, 2023 /PRNewswire/ -- From September 3 to 5, GNEC Global New Economy Conference 2023 was successfully held by NSRTimes in Macao, China.

Key Points:

MACAO, Sept. 7, 2023 /PRNewswire/ -- From September 3 to 5, GNEC Global New Economy Conference 2023 was successfully held by NSRTimes in Macao, China.
The event fostered engaging discussions on a range of hot topics, such as high technology, big health, modern finance, exhibition business, culture, and sports.
On September 4, Hao Yi, Chairman of NSRTimes, delivered a speech on behalf of the sponsor, emphasizing their support for the conference.
By doing so, the conference will contribute to the vibrant and promising future of Macao and the Greater Bay Area.

Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device

Retrieved on:

Freitag, Juli 21, 2023

Federal Food, Drug, and Cosmetic Act, Communication, POSC, Classification, Positron Corporation, Atakent (business cooperation center), PET-CT, Engineering, Molecular imaging, OTC, Affinity, FDA, LTD, Medical imaging, Positron, Neusoft

Niagara Falls, NY, July 21, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that the Company has entered an Novation Agreement with Shenyang Intelligent Neuclear Medical Technology Co, LTD (Intelligent Neuclear Medical), a wholly owned subsidiary of Neusoft Medical Systems (Neusoft), that transfers the original Business Cooperation Agreement between Positron and Neusoft Medical Systems (“Neusoft”) to now include Neusoft’s subsidiary, Intelligent Neuclear Medical.

Key Points:

Niagara Falls, NY, July 21, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that the Company has entered an Novation Agreement with Shenyang Intelligent Neuclear Medical Technology Co, LTD (Intelligent Neuclear Medical), a wholly owned subsidiary of Neusoft Medical Systems (Neusoft), that transfers the original Business Cooperation Agreement between Positron and Neusoft Medical Systems (“Neusoft”) to now include Neusoft’s subsidiary, Intelligent Neuclear Medical.
Positron has expanded its role as manufacturer with Intelligent Neuclear Medical designated as the Company’s contracted components supplier.
Positron’s classification as the device manufacturer is significant as it will register with the FDA as the applicant of its FDA 510k submission for Medical Device Clearance for its Affinity PET-CT imaging device.
Neusoft formed Intelligent Neuclear Medical as a wholly owned subsidiary to segregate all Neusoft’s current nuclear projects and products, which also includes all nuclear R&D technology initiatives.

PHI Group, Inc. and Vietnam-based Saphia Alkali JSC Sign Agreement to Provide Innovative Proprietary Products for Healthcare, Agriculture, Aquaculture and the Environment to International Markets

Retrieved on:

Mittwoch, Juni 28, 2023

According to the agreement, the companies have incorporated “Sapphire Alkali Global Group,” a Wyoming corporation, Registration ID 2023-001291498, as the parent company to implement this Business Cooperation Agreement.

Key Points:

According to the agreement, the companies have incorporated “Sapphire Alkali Global Group,” a Wyoming corporation, Registration ID 2023-001291498, as the parent company to implement this Business Cooperation Agreement.
Current Saphia Alkali JSC’s reputable healthcare products include:
Saphia Alkali Balance: a health supplement that aids in the treatment of metabolic disorders and imbalances in the body.
Saphia Alkali X300 (Saphia Alkali D-REVIE X300): a reputable health supplement that effectively supports antioxidant capacity, enhances health, helps improve resistance, and reduces fatigue.
Besides these and other healthcare-related products, Saphia Alkali JSC has also developed successful solutions for agriculture, aquaculture, and environment using its proprietary activated alkali technonogies.